Thinking Of Buying UiPath Inc (NYSE: PATH) Stock? Here Is What You Should Know

UiPath Inc (NYSE:PATH) shares, rose in value on Thursday, April 04, with the stock price up by 0.67% to the previous day’s close as strong demand from buyers drove the stock to $21.68.

Actively observing the price movement in the recent trading, the stock is buoying the session at $21.54. The value of beta (5-year monthly) is 0.97. Referring to stock’s 52-week performance, its high was $27.87, and the low was $12.38. On the whole, PATH has fluctuated by -3.28% over the past month.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

With the market capitalization of UiPath Inc currently standing at about $12.28 billion, investors are eagerly awaiting this quarter’s results, scheduled for May 22, 2024 – May 27, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0.11, which is expected to increase to $0.13 for fiscal year $0.57 and then to about $0.67 by fiscal year 2026. Data indicates that the EPS growth is expected to be 5.60% in 2026, while the next year’s EPS growth is forecast to be 17.50%.

Analysts have estimated the company’s revenue for the quarter at $333.07 million, with a low estimate of $332 million and a high estimate of $335 million. Wall Street analysts also predicted that in 2026, the company’s y-o-y revenues would reach $1.56 billion, representing an increase of 19.10% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that PATH’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 50% Buy.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of PATH currently trading nearly -6.04% and -7.90% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.00, while the 7-day volatility ratio is showing 2.52% which for the 30-day chart, stands at 3.93%. Furthermore, UiPath Inc (PATH)’s beta value is 0.96, and its average true range (ATR) is 0.86.

A comparison of UiPath Inc (PATH) with its peers suggests the former has fared considerably weaker in the market. PATH showed an intraday change of 0.67% in today’s session so far, and over the past year, it grew by 24.70%%.

Data on historical trading for UiPath Inc (NYSE:PATH) indicates that the trading volumes over the past 10 days have averaged 5.84 million and over the past 3 months, they’ve averaged 9.41 million. According to company’s latest data on outstanding shares, there are 486.82 million shares outstanding.

Nearly 23.91% of UiPath Inc’s shares belong to company insiders and institutional investors own 58.28% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 17.57 million shares as on Mar 15, 2024, resulting in a short ratio of 1.6. According to the data, the short interest in UiPath Inc (PATH) stood at 3.10% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 18.84 million. The stock has fallen by -12.70% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PATH stock heading into the next quarter.